Prognostic and predictive value of PDL1 expression in breast cancer. - Wikidata - awgldk - TriplyDB

Prognostic and predictive value of PDL1 expression in breast cancer.

Prognostic and predictive value of PDL1 expression in breast cancer.

http://www.wikidata.org/entity/Q35741710

about

The efficacy and potential predictive factors of PD-1/PD-L1 blockades in epithelial carcinoma patients: a systematic review and meta analysis Checkpoint Inhibitors and Their Application in Breast Cancer Tumor-Infiltrating Lymphocytes in Triple Negative Breast Cancer: The Future of Immune Targeting The effect of chemotherapy on programmed cell death 1/programmed cell death 1 ligand axis: some chemotherapeutical drugs may finally work through immune response Biological network-driven gene selection identifies a stromal immune module as a key determinant of triple-negative breast carcinoma prognosis.Strategies to modulate the immune system in breast cancer: checkpoint inhibitors and beyond Enhanced killing of chordoma cells by antibody-dependent cell-mediated cytotoxicity employing the novel anti-PD-L1 antibody avelumab.Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes.Emerging therapies for breast cancer Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease.New Immunotherapy Strategies in Breast Cancer.PD-L1 expression in renal cell carcinoma clear cell type is related to unfavorable prognosis PDL1 expression in inflammatory breast cancer is frequent and predicts for the pathological response to chemotherapy.Monocyte and interferon based therapy for the treatment of ovarian cancer.Prognostic and Clinicopathological Value of Programmed Death Ligand-1 in Breast Cancer: A Meta-Analysis.PD-L1 Status in Refractory Lymphomas.A Stromal Immune Module Correlated with the Response to Neoadjuvant Chemotherapy, Prognosis and Lymphocyte Infiltration in HER2-Positive Breast Carcinoma Is Inversely Correlated with Hormonal Pathways.Endocrine resistance in breast cancer--An overview and update.High PD-L1 expression was associated with poor prognosis in 870 Chinese patients with breast cancer.The Impact of PD-L1 Expression in Patients with Metastatic GEP-NETs.PD-L1 Expression Is Associated with Tumor FOXP3(+) Regulatory T-Cell Infiltration of Breast Cancer and Poor Prognosis of Patient.Variability in Immunohistochemical Detection of Programmed Death Ligand 1 (PD-L1) in Cancer Tissue Types.PD-L1 expression and CD274 gene alteration in triple-negative breast cancer: implication for prognostic biomarker.Differential tumor infiltration by T-cells characterizes intrinsic molecular subtypes in breast cancer.Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer.Therapeutic efficacy of PD-L1 blockade in a breast cancer model is enhanced by cellular vaccines expressing B7-1 and glycolipid-anchored IL-12.Expression of Programmed Death Receptor Ligand 1 with High Tumor-Infiltrating Lymphocytes Is Associated with Better Prognosis in Breast Cancer The Clinical Significance of CD169-Positive Lymph Node Macrophage in Patients with Breast Cancer.Molecular and clinical characterization of PD-L1 expression at transcriptional level via 976 samples of brain glioma.Predictive factors of the tumor immunological microenvironment for long-term follow-up in early stage breast cancer Prognostic value of PDL1 expression in pancreatic cancer Programmed Death Ligand 1 (PD-L1) Tumor Expression Is Associated with a Better Prognosis and Diabetic Disease in Triple Negative Breast Cancer Patients.Targeting of interleukin (IL)-17A inhibits PDL1 expression in tumor cells and induces anticancer immunity in an estrogen receptor-negative murine model of breast cancer PD-L1, Galectin-9 and CD8+ tumor-infiltrating lymphocytes are associated with survival in hepatocellular carcinoma.Mechanism of immune evasion in breast cancer.The combination of PD-L1 expression and decreased tumor-infiltrating lymphocytes is associated with a poor prognosis in triple-negative breast cancer.Soluble programmed death-ligand 1 (sPDL1) and neutrophil-to-lymphocyte ratio (NLR) predicts survival in advanced biliary tract cancer patients treated with palliative chemotherapy.Epigenetic modulation with histone deacetylase inhibitors in combination with immunotherapy.Role of PD-L1 expression as a biomarker for GEP neuroendocrine neoplasm grading.Immunotherapy in Breast Cancer: the Emerging Role of PD-1 and PD-L1.

P2860

Q26740280-FCE18212-5EE5-4B8B-BA21-0C169379E169 Q26745442-C6CB46C2-CF4C-4316-AAE9-FAE0E9E2E981 Q26747792-088D9917-B449-4046-95F1-4EC785E7891F Q26766066-62C202A3-1BAC-46BF-9661-45A69C5F584C Q27311085-55C1CB5C-784E-4E07-A64D-8498D1622F36 Q28077815-BBB6DEF2-B638-41BD-A4E9-9D81D84ABC36 Q33276035-FA7CFA26-8910-4866-BC3D-61F933F85A87 Q33589487-D6FDECAA-1527-498E-8D3E-803EA09ADF60 Q33617949-5ED473FB-8729-42B1-908D-5A3392F5B00C Q33769821-25EB3CCF-8084-4E0D-B240-166E9C169972 Q34549227-4D9E6E5A-124D-449D-9FEA-C3F9E338F256 Q35809165-503D73C4-DCCF-49A6-AE44-4FAC76C59B78 Q35955369-8BC9BEFC-E9AA-4568-8C95-1C2E94DA2AA2 Q35973378-B94407D5-9B2A-4B3B-94C3-28A8927EC6B4 Q36030084-96247A3D-E432-40A2-B0B7-AF7AAC485718 Q36197517-E3EDF420-C27F-4682-944A-258BD24DAEAD Q36231343-2DFE5695-1F5F-49CC-B6C7-15A1256CDF7E Q36386322-7F6EA3B2-63DD-4D4B-9029-CCE0684C12EA Q36545353-8C9B3000-5128-40DD-B53A-FAD8029571E7 Q36657306-58064F2E-CF85-45AB-89B1-374136C8E49C Q36882550-87332D21-154A-477F-940C-FF6D34F66F53 Q36939402-B3B6A366-E6BE-43D9-87E9-31A2E704EE30 Q37026725-36607437-3F02-4ED3-8EE4-BE1ED8954595 Q37138871-0D8F4B27-3C0D-416F-B0B0-E306380F28EA Q37199510-37CACE39-5EE9-4D37-BAB8-7B36DFD72DA7 Q37309250-3A1F3BFC-506D-4083-8800-6EF70EDC8DBC Q37316596-EF1EC0EC-F469-4906-89E8-F1E648A87930 Q37423348-E8845F43-8864-4E2F-8A3C-A202D47B916A Q37477267-62BFFD4A-251D-40F1-86F5-28A6D3FD0887 Q37611683-4765AE68-C342-4E21-82C9-6AA6F307FEE5 Q37687595-162F865C-EDED-4D88-B9DB-8C84426AA245 Q37691082-A5C8E6E0-4DC5-4B9A-B18E-2F9F01B2A7D3 Q37702580-9A8B432E-7AB6-4138-80DF-6A8D6587FC44 Q37705021-1C789D6D-7033-45BF-AE04-7D0BE74D6B62 Q37712385-5E8BD51E-ADCF-444E-BF7C-F30DCA1537DF Q37716582-859FB282-933C-490F-A5D6-0623E4B14A4E Q37718250-5E987B77-90FD-49D4-888E-023E6AACD814 Q38537768-A69083E5-6896-4E30-ABD4-4E8594D64810 Q38610333-B665DEFF-C4B1-4C4C-9B9E-B24C98E524E4 Q38629357-9A64F2E0-B2EE-4C43-8211-721441AA8C52

P2860

Prognostic and predictive value of PDL1 expression in breast cancer.

http://www.wikidata.org/entity/Q35741710

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Prognostic and predictive value of PDL1 expression in breast cancer.

@ast

Prognostic and predictive value of PDL1 expression in breast cancer.

@en

type

label

Prognostic and predictive value of PDL1 expression in breast cancer.

@ast

Prognostic and predictive value of PDL1 expression in breast cancer.

@en

prefLabel

Prognostic and predictive value of PDL1 expression in breast cancer.

@ast

Prognostic and predictive value of PDL1 expression in breast cancer.

@en

P1433

Q35741710-F8AF56E6-C551-4C2C-81C8-AC5F511684E9

P1476

Q35741710-9F6D51B3-E6AB-4ACF-B546-4CD0F55F62FD

P2093

Q35741710-3CC79A9D-9947-4A4A-AE5C-EEA11FB55C8D

Q35741710-463F4E48-E41E-4B48-BCBB-0788AEF8404A

Q35741710-71878766-A47C-4D66-85FB-7FC164BB6C9B

Q35741710-745DDB56-4B37-479B-A328-0C696FF7C36E

Q35741710-8756FA94-9D8A-4042-99F5-299242C87F0A

Q35741710-D915E1E8-39F4-4A25-B355-53C2B11C801C

Q35741710-F01DE7A4-D3AB-4AF9-81B2-5941C2527AFD

P2860

Q35741710-00AB670F-B0CA-43B7-ABC6-C7DAED00DA56

Q35741710-038A0D41-1D32-44D3-8A20-9A1BDE2425C0

Q35741710-039648B1-3146-4B4C-8168-E08DA84E2C98

Q35741710-07F13E25-5F58-4004-9CC5-05AE8DCC3B63

Q35741710-0E9CEF3C-F48F-4B60-A6BE-52BBF62F1662

Q35741710-1050E533-FFD4-42F6-AA61-081012E289F4

Q35741710-117FD4FC-2FD4-4710-BB16-4EA5C61036FF

Q35741710-165B92CE-BB8E-4A5C-A341-DAA78FECB029

Q35741710-1C4A39EC-27A8-43FE-AF6E-2409AB0FFCB1

Q35741710-1FC8DFF3-CD55-4DFF-BB8B-506FB9AF0CF4

P304

Q35741710-FF23A1B0-24D5-4C19-BE93-9D0ECBAE36CF

P31

Q35741710-C4471CE7-075B-4F65-8DCE-35CDB7546E78

P356

Q35741710-C8024FAB-0F57-4CCB-9D7E-C486B0831969

P407

Q35741710-6225CC48-A0EA-4705-8B1C-DC8521695DB6

P433

Q35741710-49F454F1-A603-47E0-BDA3-97BCAC4A08DF

P478

Q35741710-01CA4488-26E2-4F62-B96D-346A9B0A4FE2

P50

Q35741710-79ACBBCD-1CA3-4480-9EE9-7A811C977B65

Q35741710-9FEDD930-3588-421E-B449-D8948659248C

Q35741710-AEBFCA00-4A75-490A-836B-FEC3B7BF92EC

P577

Q35741710-94F941A4-8B54-4C70-A6DD-24CC3BD7C1B0

P5875

Q35741710-3F2779CB-FF62-4751-A319-CAEE8283E882

P698

Q35741710-6D7817B4-FAC4-4DAA-B476-122C07D487EB

P932

Q35741710-3B1CB353-F62B-49DC-90DA-0C16E19DD62E

P356

ONCOTARGET.3216

P1433

P1476

Prognostic and predictive value of PDL1 expression in breast cancer.

@en

P2093

Carlos Caldas

http://www.w3.org/2001/XMLSchema#string

Daniel Birnbaum

http://www.w3.org/2001/XMLSchema#string

Emilie Mamessier

http://www.w3.org/2001/XMLSchema#string

François Bertucci

http://www.w3.org/2001/XMLSchema#string

Hamid Raza Ali

http://www.w3.org/2001/XMLSchema#string

José Adelaide

http://www.w3.org/2001/XMLSchema#string

Pascal Finetti

http://www.w3.org/2001/XMLSchema#string

P2860

A comparison of gene expression signatures from breast tumors and breast tissue derived cell lines

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade.

Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target

Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics

Comprehensive molecular portraits of human breast tumours

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

Exploration, normalization, and summaries of high density oligonucleotide array probe level data

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

P304

5449-5464

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.3216

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Renaud Sabatier

P577

2015-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272191822

http://www.w3.org/2001/XMLSchema#string

P698

25669979

http://www.w3.org/2001/XMLSchema#string

P932

4467160

http://www.w3.org/2001/XMLSchema#string